BNTC
BNTC
NASDAQ · Biotechnology

Benitec Biopharma Inc

$11.19
+0.21 (+1.91%)
As of Mar 23, 10:06 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +140.1% upside
Low Target $21.20
Average Target $26.87
High Target $38.04
Current Price $11.19
Current
$11.19
Target
$26.87
$21.20 $26.87 avg $38.04
Scenario Analysis
Bear Case
$21.20
89.5%
Low target
Base Case
$26.87
+140.1%
Avg target
Bull Case
$38.04
+239.9%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$17.15
-34.8% from high
52-Week Low
$9.85
+13.6% from low
Target vs 52W High
$26.87
+56.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%